• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Epidemiological and Clinical Profile of COVID-19 Patients Admitted in a Tertiary Care Hospital in Western India.印度西部一家三级护理医院收治的新冠肺炎患者的流行病学和临床概况
Indian J Community Med. 2022 Jan-Mar;47(1):138-141. doi: 10.4103/ijcm.ijcm_940_21. Epub 2022 Mar 16.
2
Epidemiological and clinical characteristics of 1663 hospitalized patients infected with COVID-19 in Wuhan, China: a single-center experience.中国武汉 1663 例 COVID-19 住院患者的流行病学和临床特征:一项单中心经验。
J Infect Public Health. 2020 Sep;13(9):1202-1209. doi: 10.1016/j.jiph.2020.07.002. Epub 2020 Jul 17.
3
Evaluation of the clinical profile, laboratory parameters and outcome of two hundred COVID-19 patients from a tertiary centre in India.对来自印度一家三级中心的200例新冠肺炎患者的临床特征、实验室参数及预后进行评估。
Monaldi Arch Chest Dis. 2020 Nov 9;90(4). doi: 10.4081/monaldi.2020.1507.
4
Characteristics of COVID-19 at a non-COVID tertiary pulmonary care centre in Delhi, India.印度德里一家非新冠三级肺病护理中心的新冠病毒病特征
Monaldi Arch Chest Dis. 2020 Nov 9;90(4). doi: 10.4081/monaldi.2020.1568.
5
Clinico-epidemiological profile and outcomes of adults with COVID-19: A hospital-based retrospective study in Kerala, India.新型冠状病毒肺炎成年患者的临床流行病学特征及转归:印度喀拉拉邦一项基于医院的回顾性研究
J Family Med Prim Care. 2022 Jun;11(6):3000-3005. doi: 10.4103/jfmpc.jfmpc_2273_21. Epub 2022 Jun 30.
6
An Assessment of the Profile and Predictors of Outcomes in COVID-19 Patients Hospitalized in a Tertiary Care Institute in Central India.对印度中部一家三级医疗机构收治的新冠肺炎患者的概况及预后预测因素的评估
Cureus. 2022 Jul 16;14(7):e26909. doi: 10.7759/cureus.26909. eCollection 2022 Jul.
7
Clinical and Demographic Profile of COVID-19 Patients: A Tertiary Level Hospital-Based Study From Northeast India.新冠病毒肺炎患者的临床和人口统计学特征:一项基于印度东北部一家三级医院的研究
Cureus. 2021 Oct 19;13(10):e18881. doi: 10.7759/cureus.18881. eCollection 2021 Oct.
8
Predictors of Severity in Covid-19 Patients in Casablanca, Morocco.摩洛哥卡萨布兰卡新冠肺炎患者严重程度的预测因素
Cureus. 2020 Sep 29;12(9):e10716. doi: 10.7759/cureus.10716.
9
Trends and clinico-epidemiological profile of COVID-19 patients at a designated COVID-19 hospital in Delhi, North India.印度北部德里一家指定的新冠肺炎医院中新冠肺炎患者的趋势及临床流行病学概况。
J Family Med Prim Care. 2020 Dec 31;9(12):6261-6266. doi: 10.4103/jfmpc.jfmpc_1267_20. eCollection 2020 Dec.
10
Characteristics and outcomes of patients with COVID-19 admitted to hospital and intensive care in the first phase of the pandemic in Canada: a national cohort study.加拿大疫情第一阶段住院和重症监护的 COVID-19 患者的特征和结局:一项全国性队列研究。
CMAJ Open. 2021 Mar 8;9(1):E181-E188. doi: 10.9778/cmajo.20200250. Print 2021 Jan-Mar.

引用本文的文献

1
Inflammatory biomarkers and adverse outcome in COVID-19: Prelude for future viral pandemics.新冠病毒肺炎中的炎症生物标志物与不良结局:未来病毒性大流行的前奏
J Family Med Prim Care. 2025 Feb;14(2):720-728. doi: 10.4103/jfmpc.jfmpc_1326_24. Epub 2025 Feb 21.
2
Clinico-epidemiological profile of non-survivors of COVID-19 during the last two waves in a tertiary care hospital of North India: A retrospective descriptive study.印度北部一家三级护理医院过去两波新冠疫情期间新冠病毒病死亡患者的临床流行病学概况:一项回顾性描述性研究
J Family Med Prim Care. 2023 Oct;12(10):2385-2391. doi: 10.4103/jfmpc.jfmpc_307_23. Epub 2023 Oct 11.

本文引用的文献

1
Trends and clinico-epidemiological profile of COVID-19 patients at a designated COVID-19 hospital in Delhi, North India.印度北部德里一家指定的新冠肺炎医院中新冠肺炎患者的趋势及临床流行病学概况。
J Family Med Prim Care. 2020 Dec 31;9(12):6261-6266. doi: 10.4103/jfmpc.jfmpc_1267_20. eCollection 2020 Dec.
2
Epidemiological profile of SARS-CoV-2 among selected regions in Ghana: A cross-sectional retrospective study.加纳部分地区 SARS-CoV-2 的流行病学特征:一项横断面回顾性研究。
PLoS One. 2020 Dec 10;15(12):e0243711. doi: 10.1371/journal.pone.0243711. eCollection 2020.
3
Epidemiological and Clinical Characteristics of 6635 COVID-19 Patients: a Pooled Analysis.6635例新冠病毒肺炎患者的流行病学和临床特征:一项汇总分析
SN Compr Clin Med. 2020;2(8):1048-1052. doi: 10.1007/s42399-020-00393-y. Epub 2020 Jul 9.
4
Comorbidity and its Impact on Patients with COVID-19.合并症及其对COVID-19患者的影响。
SN Compr Clin Med. 2020;2(8):1069-1076. doi: 10.1007/s42399-020-00363-4. Epub 2020 Jun 25.
5
Epidemiological and clinical characteristics of the COVID-19 epidemic in Brazil.巴西 COVID-19 疫情的流行病学和临床特征。
Nat Hum Behav. 2020 Aug;4(8):856-865. doi: 10.1038/s41562-020-0928-4. Epub 2020 Jul 31.
6
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 disease.用于确定在基层医疗或医院门诊就诊的患者是否患有新冠病毒病的体征和症状。
Cochrane Database Syst Rev. 2020 Jul 7;7(7):CD013665. doi: 10.1002/14651858.CD013665.
7
Epidemiological and clinical features of 2019 novel coronavirus diseases (COVID-19) in the South of Iran.伊朗南部2019新型冠状病毒病(COVID-19)的流行病学和临床特征
BMC Infect Dis. 2020 Jun 18;20(1):427. doi: 10.1186/s12879-020-05128-x.
8
Mild versus severe COVID-19: Laboratory markers.轻症与重症 COVID-19:实验室标志物。
Int J Infect Dis. 2020 Jun;95:304-307. doi: 10.1016/j.ijid.2020.04.061. Epub 2020 Apr 25.
9
Clinical and epidemiologic profile of the initial COVID-19 patients at a tertiary care centre in India.印度一家三级医疗中心首批新冠肺炎患者的临床及流行病学概况
Monaldi Arch Chest Dis. 2020 Apr 10;90(1). doi: 10.4081/monaldi.2020.1294.
10
Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) - United States, February 12-March 16, 2020.2020 年 2 月 12 日至 3 月 16 日,美国 2019 冠状病毒病(COVID-19)患者的严重结局。
MMWR Morb Mortal Wkly Rep. 2020 Mar 27;69(12):343-346. doi: 10.15585/mmwr.mm6912e2.

印度西部一家三级护理医院收治的新冠肺炎患者的流行病学和临床概况

Epidemiological and Clinical Profile of COVID-19 Patients Admitted in a Tertiary Care Hospital in Western India.

作者信息

Jain Shikha, Raval Devang A, Mitra Aarohi, Chaudhary Diksha, Khare Utkarsh

机构信息

Department of Community Medicine, B.J. Medical College, Ahmedabad, Gujarat, India.

出版信息

Indian J Community Med. 2022 Jan-Mar;47(1):138-141. doi: 10.4103/ijcm.ijcm_940_21. Epub 2022 Mar 16.

DOI:10.4103/ijcm.ijcm_940_21
PMID:35368499
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8971864/
Abstract

INTRODUCTION

Ahmedabad city reported the highest number of cases and deaths. In order to guide various interventions and monitor future trends, evidence is required. Hence, we conducted the present study to explore the epidemiological determinants, clinical profile, risk factors, and predictors of mortality of COVID-19.

METHODS

This was a retrospective record-based descriptive study of 2268 confirmed COVID-19 patients admitted in a designated COVID hospital of Ahmedabad city from March to July 2020.

RESULTS

The median age of patients was 54 years, and 60.9% of them were males. Majority (83.27%) had comorbidities; the most common comorbidity was hypertension (62.59%) followed by diabetes (44.76%). The most common symptoms reported were fever (69.76%), breathlessness (55.47%), and cough (53.18%). Majority (61.12%) of the patients showed lymphocytopenia, and in one-third (34.85%), D-dimer levels were elevated (>1 μg/ml). Odds of inhospital deaths were higher in patients having breathlessness and gastrointestinal symptoms and comorbidities. More of the deceased had leukocytosis and lymphocytopenia, high D-dimer levels, C-reactive protein, and altered liver function tests as compared to the survivors.

CONCLUSION

While making decisions such as prevention of exposure of high-risk population to the infection, control of the existing comorbid condition, and prioritization of this population for vaccination, criteria of case definition for surveillance keeping in mind the typical and atypical manifestations of the disease, require robust evidence which the current study could provide insight to.

摘要

引言

艾哈迈达巴德市报告的病例数和死亡数最多。为指导各项干预措施并监测未来趋势,需要相关证据。因此,我们开展了本研究,以探索新冠肺炎的流行病学决定因素、临床特征、危险因素及死亡预测因素。

方法

这是一项基于回顾性记录的描述性研究,研究对象为2020年3月至7月在艾哈迈达巴德市一家指定新冠肺炎医院收治的2268例确诊新冠肺炎患者。

结果

患者的中位年龄为54岁,其中60.9%为男性。大多数(83.27%)患者有合并症;最常见的合并症是高血压(62.59%),其次是糖尿病(44.76%)。报告的最常见症状为发热(69.76%)、呼吸困难(55.47%)和咳嗽(53.18%)。大多数(61.12%)患者出现淋巴细胞减少,三分之一(34.85%)患者的D-二聚体水平升高(>1μg/ml)。有呼吸困难、胃肠道症状和合并症患者的院内死亡几率更高。与幸存者相比,死亡患者的白细胞增多、淋巴细胞减少、D-二聚体水平高、C反应蛋白及肝功能检查异常更为常见。

结论

在做出诸如预防高危人群感染、控制现有合并症以及将该人群列为疫苗接种优先对象等决策时,考虑到该疾病的典型和非典型表现的监测病例定义标准,需要有力的证据,而本研究能够为此提供见解。